The U.S. Food and Drug Administration has declined to approve Corcept Therapeutics' drug for the treatment of a rare hormonal ...
Vanda Pharmaceuticals said on Tuesday its drug for the prevention of motion-induced vomiting was approved by the U.S. health ...
The FDA has issued a complete response letter for an oral selective glucocorticoid receptor antagonist under investigation ...
Louisiana argues the FDA’s rule directly interferes with its ability to enforce those laws by facilitating the mailing of ...
The FDA has approved Deseyne contact lenses with extended depth of focus for the correction of presbyopia, according to a ...
The FDA has approved the first GLP-1 pill for weight loss and it's expected in pharmacies in the coming weeks. Dr. Holly ...
The FDA has announced a recall of frozen raw shrimp due to potential exposure to the radioactive isotope cesium-137. The FDA ...
MedPage Today on MSN
Five Leaders in One Year: FDA's Drug Center Enters 2026 at a Crossroads
The FDA appointed George Tidmarsh, MD, PhD, to be the nation's top drug official in July. The Center for Drug Evaluation and ...
The U.S. Food and Drug Administration on Dec. 22 approved a pill version of Novo Nordisk’s weight-loss drug Wegovy.
The US saw several new and expanded FDA indications this year. The top 5 most-read FDA approvals on AJMC.com included 4 novel ...
The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets for the treatment of progressive pulmonary ...
A new proposal in JAMA Internal Medicine suggests that the FDA should create an approval pathway for medical AI tools that parallels how physicians are trained and licensed.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results